SlideShare uma empresa Scribd logo
1 de 45
DRUG DEVELOPMENT AND REGULATION www.freelivedoctor.com
Historical Background Why were Laws Needed? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Virus  Toxin Act of 1902   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
Food and Drug Act of l906 (Wiley or Heyburn Act)   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
The Sherley Amendment of l912   ,[object Object],[object Object],www.freelivedoctor.com
The Food, Drug and Cosmetic Act of l938 (Copeland Act)   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
The Federal Insecticide, Fungicide and Rodenticide Act (FIFRA) Act – l947   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
The Durham Humphrey Amendment of l951   ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Insulin and Antibiotic Certification Amendments ’41, ’43, ’45, ’49, ’52   ,[object Object],[object Object],www.freelivedoctor.com
The Kefauver – Harris Act of l962   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
DESI Evaluation of l966; completed l969-70   ,[object Object],www.freelivedoctor.com
Comprehensive Drug Abuse Prevention and Control Act of 1970   ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Important Legislative Developments of the 70’s ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Orphan Drug Act of 1983   ,[object Object],[object Object],www.freelivedoctor.com
Drug Price Competition and Patent Term Restoration Act – 1984   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
Generic Drugs Act – 1990   ,[object Object],[object Object],www.freelivedoctor.com
Prescription Drug User Fee Act (PDUFA) of l994; l997; 2000; 2003   ,[object Object],[object Object],www.freelivedoctor.com
FDA Modernization Act - l997   ,[object Object],[object Object],www.freelivedoctor.com
Pediatric Exclusivity Act of 1998 ,[object Object],[object Object],www.freelivedoctor.com
Drug Development - Methods used to identify compounds with potential therapeutic usefulness   ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Synthesis, Purification & Data Mining ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Animal Studies - Preclinical Studies   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Animal Studies - Preclinical Studies  ,[object Object],[object Object],[object Object],www.freelivedoctor.com
Animal Studies - Preclinical Studies   ,[object Object],[object Object],[object Object],www.freelivedoctor.com
Clinical Studies   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Clinical Studies (continued) ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
Clinical Studies (continued) ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
www.freelivedoctor.com
DEFINITION OF A NEW DRUG   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
INVESTIGATIONAL NEW DRUG APPLICATION (IND) ,[object Object],www.freelivedoctor.com
INVESTIGATIONAL NEW DRUG APPLICATION (IND) ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
INVESTIGATIONAL NEW DRUG APPLICATION (IND) ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE I STUDIES ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE I STUDIES ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE II STUDIES   ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE II STUDIES   ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE III STUDIES   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE III STUDIES   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
THE NEW DRUG APPLICATION (NDA)     ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
THE NEW DRUG APPLICATION (NDA)     ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
THE NEW DRUG APPLICATION (NDA)     ,[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE IV – POSTMARKETING SURVEILLANCE   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
PHASE IV – POSTMARKETING SURVEILLANCE   ,[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
CLASSIFICATION SYSTEM Type - Review Priorities  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com
CLASSIFICATION SYSTEM Type - Review Priorities  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],www.freelivedoctor.com

Mais conteúdo relacionado

Mais procurados

Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.PakistanPharmaCareerDoor
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIJafarali Masi
 
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)GOKULAKRISHNAN S
 
Investigational medical product dossier
Investigational medical product dossierInvestigational medical product dossier
Investigational medical product dossierSachinFartade
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchRajeswariS12
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiashabana parveen
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoAnthony Melvin Crasto Ph.D
 
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessThe Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessCarrie O'Connor
 
Non clinical drug development
Non clinical drug developmentNon clinical drug development
Non clinical drug developmentRama Shukla
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveAYESHA NAZEER
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.Audumbar Mali
 
Regulatory framework for new drug development
Regulatory framework for new drug developmentRegulatory framework for new drug development
Regulatory framework for new drug developmentDr. Mohit Kulmi
 

Mais procurados (20)

Nda ipr
Nda  iprNda  ipr
Nda ipr
 
FDA’s drug review process
FDA’s drug review processFDA’s drug review process
FDA’s drug review process
 
Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.Lecture # 03 New Drug Approval and Development Process.
Lecture # 03 New Drug Approval and Development Process.
 
USFDA NDA Vs BLA
USFDA NDA Vs BLAUSFDA NDA Vs BLA
USFDA NDA Vs BLA
 
Drug approval process
Drug approval processDrug approval process
Drug approval process
 
Regulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy IIRegulatory requirements for drug approval - industrial pharmacy II
Regulatory requirements for drug approval - industrial pharmacy II
 
NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)NEW DRUG APPLICATION (NDA)
NEW DRUG APPLICATION (NDA)
 
Investigational medical product dossier
Investigational medical product dossierInvestigational medical product dossier
Investigational medical product dossier
 
Center for Biologics Evaluation and Research
Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research
Center for Biologics Evaluation and Research
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
 
Orange book
Orange bookOrange book
Orange book
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
What is FDA?
What is FDA?What is FDA?
What is FDA?
 
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
 
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessThe Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) Process
 
Quality assuarance
Quality assuaranceQuality assuarance
Quality assuarance
 
Non clinical drug development
Non clinical drug developmentNon clinical drug development
Non clinical drug development
 
IND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspectiveIND (Investigational New Drug) industrial perspective
IND (Investigational New Drug) industrial perspective
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
 
Regulatory framework for new drug development
Regulatory framework for new drug developmentRegulatory framework for new drug development
Regulatory framework for new drug development
 

Destaque

Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Hypo & hyperthyriodism
Hypo & hyperthyriodismHypo & hyperthyriodism
Hypo & hyperthyriodismraj kumar
 
Bronchodilators
BronchodilatorsBronchodilators
Bronchodilatorsraj kumar
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agentsraj kumar
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapyraj kumar
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychoticsraj kumar
 
Local anesthetics
Local anestheticsLocal anesthetics
Local anestheticsraj kumar
 
Cns depressants
Cns depressantsCns depressants
Cns depressantsraj kumar
 
Drugs and the kidney
Drugs and the kidneyDrugs and the kidney
Drugs and the kidneyraj kumar
 
Pulmonary pathology copd
Pulmonary pathology copdPulmonary pathology copd
Pulmonary pathology copdraj kumar
 
Acid peptic disease nsaids
Acid peptic disease  nsaidsAcid peptic disease  nsaids
Acid peptic disease nsaidsraj kumar
 
Drug development
Drug developmentDrug development
Drug developmentraj kumar
 
Antiarrhythmicdrugs
AntiarrhythmicdrugsAntiarrhythmicdrugs
Antiarrhythmicdrugsraj kumar
 
Antilipemics
AntilipemicsAntilipemics
Antilipemicsraj kumar
 
Antidysrhythmics
AntidysrhythmicsAntidysrhythmics
Antidysrhythmicsraj kumar
 
Antimicrobe drugs -grossly
Antimicrobe drugs -grosslyAntimicrobe drugs -grossly
Antimicrobe drugs -grosslyraj kumar
 
Pain & analgesia
Pain & analgesiaPain & analgesia
Pain & analgesiaraj kumar
 
Initiation &management of drug therapy
Initiation &management of drug therapyInitiation &management of drug therapy
Initiation &management of drug therapyraj kumar
 
Endocrine disruptor
Endocrine disruptorEndocrine disruptor
Endocrine disruptorraj kumar
 

Destaque (20)

Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Hypo & hyperthyriodism
Hypo & hyperthyriodismHypo & hyperthyriodism
Hypo & hyperthyriodism
 
Bronchodilators
BronchodilatorsBronchodilators
Bronchodilators
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
Cancer chemotherapy
Cancer chemotherapyCancer chemotherapy
Cancer chemotherapy
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Local anesthetics
Local anestheticsLocal anesthetics
Local anesthetics
 
Ihd
IhdIhd
Ihd
 
Cns depressants
Cns depressantsCns depressants
Cns depressants
 
Drugs and the kidney
Drugs and the kidneyDrugs and the kidney
Drugs and the kidney
 
Pulmonary pathology copd
Pulmonary pathology copdPulmonary pathology copd
Pulmonary pathology copd
 
Acid peptic disease nsaids
Acid peptic disease  nsaidsAcid peptic disease  nsaids
Acid peptic disease nsaids
 
Drug development
Drug developmentDrug development
Drug development
 
Antiarrhythmicdrugs
AntiarrhythmicdrugsAntiarrhythmicdrugs
Antiarrhythmicdrugs
 
Antilipemics
AntilipemicsAntilipemics
Antilipemics
 
Antidysrhythmics
AntidysrhythmicsAntidysrhythmics
Antidysrhythmics
 
Antimicrobe drugs -grossly
Antimicrobe drugs -grosslyAntimicrobe drugs -grossly
Antimicrobe drugs -grossly
 
Pain & analgesia
Pain & analgesiaPain & analgesia
Pain & analgesia
 
Initiation &management of drug therapy
Initiation &management of drug therapyInitiation &management of drug therapy
Initiation &management of drug therapy
 
Endocrine disruptor
Endocrine disruptorEndocrine disruptor
Endocrine disruptor
 

Semelhante a Drug development and regulation

Drug development process and regulatory submissions
Drug development process and regulatory submissionsDrug development process and regulatory submissions
Drug development process and regulatory submissionsSuyog
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationDr. Jigar Vyas
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONKomal Yadav
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATIONRoshan Bodhe
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Clinical Trials & Drug Approval Process
Clinical Trials & Drug Approval ProcessClinical Trials & Drug Approval Process
Clinical Trials & Drug Approval ProcessKumaraguru Veerasamy
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugsSultan Alharbi
 
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxPART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxDilsarGohil1
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...Audumbar Mali
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentJonathan Servoss
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.Audumbar Mali
 
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleRegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleHarunMohamed7
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentSujith Thokala
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsArpitha Aarushi
 

Semelhante a Drug development and regulation (20)

Drug development process and regulatory submissions
Drug development process and regulatory submissionsDrug development process and regulatory submissions
Drug development process and regulatory submissions
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug Application
 
INVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATIONINVESTIGATIONAL NEW DRUG APPLICATION
INVESTIGATIONAL NEW DRUG APPLICATION
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 
ANDA FDA APPLICATION
ANDA FDA APPLICATIONANDA FDA APPLICATION
ANDA FDA APPLICATION
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
USFDA
USFDAUSFDA
USFDA
 
Naresh... anda ppt
Naresh... anda pptNaresh... anda ppt
Naresh... anda ppt
 
Clinical Trials & Drug Approval Process
Clinical Trials & Drug Approval ProcessClinical Trials & Drug Approval Process
Clinical Trials & Drug Approval Process
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugs
 
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptxPART 1 _ Documentation of drug trials and regulatory filings (1).pptx
PART 1 _ Documentation of drug trials and regulatory filings (1).pptx
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
 
The Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory EnvironmentThe Rough Waters of the Regulatory Environment
The Rough Waters of the Regulatory Environment
 
Anda 2011 ppt raaj gprac
Anda 2011 ppt raaj gpracAnda 2011 ppt raaj gprac
Anda 2011 ppt raaj gprac
 
5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
RegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycleRegulatoryIssues In Drug management cycle
RegulatoryIssues In Drug management cycle
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 
Regulatory requirement for approval of Biologics
Regulatory requirement for approval of BiologicsRegulatory requirement for approval of Biologics
Regulatory requirement for approval of Biologics
 

Mais de raj kumar

The umbilical cord
The umbilical cordThe umbilical cord
The umbilical cordraj kumar
 
The placenta
The placentaThe placenta
The placentaraj kumar
 
The foetal membranes
The foetal membranesThe foetal membranes
The foetal membranesraj kumar
 
Physiology of reproduction
Physiology of reproductionPhysiology of reproduction
Physiology of reproductionraj kumar
 
Minor complaints during pregnancy
Minor complaints during pregnancyMinor complaints during pregnancy
Minor complaints during pregnancyraj kumar
 
Diagnosis of pregnancy
Diagnosis of pregnancyDiagnosis of pregnancy
Diagnosis of pregnancyraj kumar
 
Antenatal care
Antenatal careAntenatal care
Antenatal careraj kumar
 
Postpartum mood disorders
Postpartum mood disordersPostpartum mood disorders
Postpartum mood disordersraj kumar
 
Normal and abnormal puerperium
Normal and abnormal puerperiumNormal and abnormal puerperium
Normal and abnormal puerperiumraj kumar
 
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)Vacuum extraction (ventouse)
Vacuum extraction (ventouse)raj kumar
 
Symphysiotomy
SymphysiotomySymphysiotomy
Symphysiotomyraj kumar
 
Forceps delivery
Forceps deliveryForceps delivery
Forceps deliveryraj kumar
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean sectionraj kumar
 
Normal labour
Normal labourNormal labour
Normal labourraj kumar
 
Anatomy of the foetal skull
Anatomy of the foetal skullAnatomy of the foetal skull
Anatomy of the foetal skullraj kumar
 
Anatomy of the female pelvis
Anatomy of the female pelvisAnatomy of the female pelvis
Anatomy of the female pelvisraj kumar
 
Active management of normal labour
Active management of normal labourActive management of normal labour
Active management of normal labourraj kumar
 
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyThyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyraj kumar
 

Mais de raj kumar (20)

The umbilical cord
The umbilical cordThe umbilical cord
The umbilical cord
 
The placenta
The placentaThe placenta
The placenta
 
The foetal membranes
The foetal membranesThe foetal membranes
The foetal membranes
 
Physiology of reproduction
Physiology of reproductionPhysiology of reproduction
Physiology of reproduction
 
Minor complaints during pregnancy
Minor complaints during pregnancyMinor complaints during pregnancy
Minor complaints during pregnancy
 
Diagnosis of pregnancy
Diagnosis of pregnancyDiagnosis of pregnancy
Diagnosis of pregnancy
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
Postpartum mood disorders
Postpartum mood disordersPostpartum mood disorders
Postpartum mood disorders
 
Normal and abnormal puerperium
Normal and abnormal puerperiumNormal and abnormal puerperium
Normal and abnormal puerperium
 
Version
VersionVersion
Version
 
Vacuum extraction (ventouse)
Vacuum extraction (ventouse)Vacuum extraction (ventouse)
Vacuum extraction (ventouse)
 
Symphysiotomy
SymphysiotomySymphysiotomy
Symphysiotomy
 
Forceps delivery
Forceps deliveryForceps delivery
Forceps delivery
 
Episiotomy
EpisiotomyEpisiotomy
Episiotomy
 
Caesarean section
Caesarean sectionCaesarean section
Caesarean section
 
Normal labour
Normal labourNormal labour
Normal labour
 
Anatomy of the foetal skull
Anatomy of the foetal skullAnatomy of the foetal skull
Anatomy of the foetal skull
 
Anatomy of the female pelvis
Anatomy of the female pelvisAnatomy of the female pelvis
Anatomy of the female pelvis
 
Active management of normal labour
Active management of normal labourActive management of normal labour
Active management of normal labour
 
Thyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancyThyrotoxicosis in pregnancy
Thyrotoxicosis in pregnancy
 

Drug development and regulation

  • 1. DRUG DEVELOPMENT AND REGULATION www.freelivedoctor.com
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.
  • 44.
  • 45.